1. Home
  2. SMID vs STTK Comparison

SMID vs STTK Comparison

Compare SMID & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMID
  • STTK
  • Stock Information
  • Founded
  • SMID 1960
  • STTK 2016
  • Country
  • SMID United States
  • STTK United States
  • Employees
  • SMID N/A
  • STTK N/A
  • Industry
  • SMID Building Materials
  • STTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMID Industrials
  • STTK Health Care
  • Exchange
  • SMID Nasdaq
  • STTK Nasdaq
  • Market Cap
  • SMID 166.5M
  • STTK 56.8M
  • IPO Year
  • SMID 1995
  • STTK 2020
  • Fundamental
  • Price
  • SMID $39.43
  • STTK $1.12
  • Analyst Decision
  • SMID
  • STTK Hold
  • Analyst Count
  • SMID 0
  • STTK 3
  • Target Price
  • SMID N/A
  • STTK $2.00
  • AVG Volume (30 Days)
  • SMID 22.1K
  • STTK 182.2K
  • Earning Date
  • SMID 11-14-2024
  • STTK 02-27-2025
  • Dividend Yield
  • SMID N/A
  • STTK N/A
  • EPS Growth
  • SMID 1025.92
  • STTK N/A
  • EPS
  • SMID 1.22
  • STTK N/A
  • Revenue
  • SMID $76,366,000.00
  • STTK $6,435,000.00
  • Revenue This Year
  • SMID N/A
  • STTK $313.04
  • Revenue Next Year
  • SMID N/A
  • STTK N/A
  • P/E Ratio
  • SMID $31.93
  • STTK N/A
  • Revenue Growth
  • SMID 32.40
  • STTK 382.75
  • 52 Week Low
  • SMID $25.03
  • STTK $0.94
  • 52 Week High
  • SMID $51.96
  • STTK $11.76
  • Technical
  • Relative Strength Index (RSI)
  • SMID 37.98
  • STTK 43.75
  • Support Level
  • SMID $37.70
  • STTK $1.13
  • Resistance Level
  • SMID $40.20
  • STTK $1.39
  • Average True Range (ATR)
  • SMID 2.17
  • STTK 0.11
  • MACD
  • SMID -0.81
  • STTK 0.00
  • Stochastic Oscillator
  • SMID 17.40
  • STTK 18.18

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

Share on Social Networks: